About Indaptus Therapeutics, Inc. - Common Stock (INDP)
Indaptus Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with serious and life-threatening diseases. The company specializes in leveraging advanced technologies to create novel treatments that aim to harness the body's immune system and improve therapeutic outcomes. By advancing its pipeline of drug candidates, Indaptus Therapeutics seeks to address unmet medical needs and provide new hope for patients suffering from various forms of cancer and other challenging conditions. Read More
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
